Comparison of Side Effects of Levofloxacin versus Other Fluoroquinolones

  title={Comparison of Side Effects of Levofloxacin versus Other Fluoroquinolones},
  author={Claude Carb{\'o}n},
  pages={9 - 14}
The side-effect profile of levofloxacin was compared with that of other fluoroquinolones based on European and international data from approximately 130 million prescriptions. Levofloxacin was found to be very safe with a low rate of hepatic abnormalities (1/650,000). In contrast, 140 trovafloxacin-treated patients developed hepatic problems, 14 of which were severe, and 8 required transplantation. The main CNS problems associated with fluoroquinolones include dizziness, convulsions, psychosis… 

Tables from this paper

Maximizing Pharmacodynamics with High-Dose Levofloxacin

The levofloxacin 750 mg dosage formulation is a logical option when evaluating the antimicrobial armamentarium commonly utilized for the empiric treatment of CAP, NAP, and SSSI and pharmacodynamic parameters are optimized and resistance is minimized when high-dose, short-course therapy is implemented.

Pulmonary Toxicity with Fluoroquinolones

Two cases of hypersensitive pneumonitis with vasculitis followed exposure to ciprofloxacin and/or levofloxac in patients younger than 30 years old are reported.

Levofloxacin for the treatment of pyelonephritis

Levofloxacin is no longer a suitable option for first-line empirical treatment of pyelonephritis in areas where resistance rates are high (> 10%) when pyel onephritis is hospital-acquired and its prescription should be performed in compliance with antimicrobial guidelines.

Levofloxacin induced Desquamation: A Rare Case Report.

A case report of levofloxacin-induced desquamation in an India patient will help to keep physicians vigilant about the current Adverse Drug Reaction, helping in early detection and management of ADR.

Levofloxacin Induced Stomatitis: A Case Report

Stomatitis can affect any of the tissues in the mouth: cheeks, tongue, gums, throat, lips, and plate and the fluoroquinolones are a large group of antibiotics which have a safe and effective profile.

A Review of Levofloxacin for the Treatment of Bacterial Infections

Completing its initial phases of drug development in the mid 1990s as the one of the first fluoroquinolones that could be used with confidence to treat respiratory tract infections, levofloxacin went

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.

In adult MDR-TB patients, standard dosing of once-daily 1000 mg levofloxacin in TB treatment did not consistently attain the target concentration, leaving them at risk of developing drug resistance, so therapeutic drug monitoring for patients with strains having MICs of ≥0.5 mg/L is recommended and the cut-off value is suggested from 2 to 1mg/L.

Miscellaneous antibacterial drugs

Fluoroquinolone‐Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?

A comprehensive summary of the risk of tendinopathy associated with levofloxacin, one of the most widely prescribed antibiotics in the United States, across in vitro, animal, and clinical studies, relative to other antibiotics is provided.


Comparative Tolerability of the Newer Fluoroquinolone Antibacterials

Among the newer fluoroquinolones, clinically significant cardiac events are rare or absent but possible interactions in patients receiving other drugs capable of causing QT prolongation should be anticipated.